(en) D. Gonzalez-Ramirez, M. Zuniga-Charles, A. Narro-Juarez, Y. Molina-Recio, K. M. Hurlbut, R. C. Dart and H. V. Aposhian, « DMPS (2,3-Dimercaptopropane-1-sulfonate, Dimaval) Decreases the Body Burden of Mercury in Humans Exposed to Mercurous Chloride », J. Pharmacol. Exp. Ther., vol. 287, no 1, , p. 8–12 (PMID9765315, lire en ligne)
doi.org
dx.doi.org
(en) H.V. Aposhian et M.M. Aposhian, « Meso-2,3-dimercaptosuccinic acid: Chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. », Annu. Rev. Pharmacol. Toxicol., vol. 30, no 1, , p. 279–306 (DOI10.1146/annurev.pa.30.040190.001431)
James Rooney, « The role of thiols, dithiols, nutritional factors and
interacting ligands in the toxicology of mercury », Toxicology, vol. 234, , p. 145–156 (DOI10.1016/j.tox.2007.02.016)
GianPaolo Guzzi et Caterina A.M. La Porta, « Molecular mechanisms triggered by mercury », Toxicology, vol. 244, , p. 1–12 (DOI10.1016/j.tox.2007.11.002)
nih.gov
ncbi.nlm.nih.gov
(en) D. Gonzalez-Ramirez, M. Zuniga-Charles, A. Narro-Juarez, Y. Molina-Recio, K. M. Hurlbut, R. C. Dart and H. V. Aposhian, « DMPS (2,3-Dimercaptopropane-1-sulfonate, Dimaval) Decreases the Body Burden of Mercury in Humans Exposed to Mercurous Chloride », J. Pharmacol. Exp. Ther., vol. 287, no 1, , p. 8–12 (PMID9765315, lire en ligne)
AA Van der Linde, S Pillen, GP Gerrits et JN Bouwes Bavinck, « Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy », Clin. Toxicol., vol. 46, no 5, , p. 479–81 (PMID18568806)
